Literature DB >> 11455066

The role of citicholine in neuropsychological training after traumatic brain injury.

José León-Carrión1, José María Dominguez-Roldán, Francisco Murillo-Cabezas, María del Rosario Dominguez-Morales, María Angeles Muñoz-Sanchez.   

Abstract

Objective: To report new strategies in the treatment of persistent memory deficits following traumatic brain injury (TBI) using a combination of pharmacology and neuropsychological training. Study design: Two studies were carried out. The first study measured the regional cerebral blood flow (rCBF) of seven Patients with TBI with very severe memory deficits, once while resting and once one hour after the administration of citicholine (CDPc). In the second study, two groups of five patients of the same characteristics underwent an ecological neuropsychological memory rehabilitation program; during which time, one group was administered a placebo (Group A), and the other received CDPc (1~g/d v.o.) (Group B).
Results: The results of Experiment 1 showed a hypoperfusion of the inferior left temporal cerebral blood flow during rest state while an induced normalization was observed after administration of the drug. Results of Experiment 2 showed no improvements in Group A's neuropsychological functions, while memory, learning processes and verbal fluency of Group B improved significantly after treatment. Conclusions: CDP-choline seems to be a drug with special affinity for cerebral areas associated with memory acting just where needed, normalizing blood flow in the hypoperfused left temporo-basal region, and making neuropsychological training effective. In general, data suggests that cognitive rehabilitation would follow the principle of first restoring and maintaining cerebral blood flow in the lesional site and then exercising function. In this study on memory rehabilitation, memory recuperation was made possible by first normalizing blood flow at the lesional site and at the same time applying neuropsychological training.

Entities:  

Year:  2000        PMID: 11455066

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  10 in total

1.  Beneficial effect of HHI-I on cerebral microcirculation, blood-brain barrier in rats and anti-hypoxic activity in mice.

Authors:  Lian-gen Zhao; Xian-zhong Wu; Xiao-xian Wu
Journal:  Chin J Integr Med       Date:  2009-04-29       Impact factor: 1.978

2.  Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.

Authors:  Helmut Trimmel; Marek Majdan; Andrea Wodak; Guenther Herzer; Daniel Csomor; Alexandra Brazinova
Journal:  Wien Klin Wochenschr       Date:  2017-07-27       Impact factor: 1.704

3.  Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network.

Authors:  Emilia Bagiella; Thomas A Novack; Beth Ansel; Ramon Diaz-Arrastia; Sureyya Dikmen; Tessa Hart; Nancy Temkin
Journal:  J Head Trauma Rehabil       Date:  2010 Sep-Oct       Impact factor: 2.710

Review 4.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 5.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

6.  Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury.

Authors:  Maria V Guseva; Deann M Hopkins; Stephen W Scheff; James R Pauly
Journal:  J Neurotrauma       Date:  2008-08       Impact factor: 5.269

7.  The citicoline brain injury treatment (COBRIT) trial: design and methods.

Authors:  Ross Zafonte; William T Friedewald; Shing M Lee; Bruce Levin; Ramon Diaz-Arrastia; Beth Ansel; Howard Eisenberg; Shelly D Timmons; Nancy Temkin; Thomas Novack; Joseph Ricker; Randall Merchant; Jack Jallo
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 8.  Role of Citicoline in the Management of Traumatic Brain Injury.

Authors:  Julio J Secades
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

9.  Citicoline for traumatic brain injury: a systematic review & meta-analysis.

Authors:  Ali Meshkini; Mohammad Meshkini; Homayoun Sadeghi-Bazargani
Journal:  J Inj Violence Res       Date:  2017-01-01

Review 10.  Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.

Authors:  Sana Javaid; Talha Farooq; Zohabia Rehman; Ammara Afzal; Waseem Ashraf; Muhammad Fawad Rasool; Faleh Alqahtani; Sary Alsanea; Fawaz Alasmari; Mohammed Mufadhe Alanazi; Metab Alharbi; Imran Imran
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.